Upgrade to SI Premium - Free Trial

Edesa Biotech (EDSA)

2.99 +0.14 (4.91%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/14/25 *Est.)

Latest Headlines

Form 8-K Edesa Biotech, Inc. For: Oct 15 October 15, 2026 9:15 AM - SEC Filing FDA clears Edesa Biotech IND for Phase 2 vitiligo drug study October 15, 2026 9:15 AM - StreetInsider Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study October 15, 2026 9:15 AM - Globe NewsWire Form 4 Edesa Biotech, Inc. For: Oct 05 Filed by: Nijhawan Pardeep October 6, 2026 5:06 PM - SEC Filing Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Stonepine Capital Management, LLC August 26, 2026 4:41 PM - SEC Filing Form SCHEDULE 13D/A Edesa Biotech, Inc. Filed by: Nijhawan Pardeep August 25, 2026 6:01 PM - SEC Filing Form SCHEDULE 13D/A Edesa Biotech, Inc. Filed by: Velan Capital Investment Management LP August 25, 2026 4:39 PM - SEC Filing Form 8-K Edesa Biotech, Inc. For: Aug 19 August 20, 2026 4:15 PM - SEC Filing Form 424B5 Edesa Biotech, Inc. August 20, 2026 4:10 PM - SEC Filing Edesa Biotech prices $25M public offering on Nasdaq August 19, 2026 10:20 PM - StreetInsider Edesa Biotech Announces Pricing of $25.0 Million Public Offering August 19, 2026 10:20 PM - Globe NewsWire Form 424B5 Edesa Biotech, Inc. August 19, 2026 4:06 PM - SEC Filing Edesa Biotech launches public offering of common shares August 19, 2026 4:01 PM - StreetInsider Edesa Biotech Announces Proposed Public Offering August 19, 2026 4:01 PM - Globe NewsWire Form 10-Q Edesa Biotech, Inc. For: Jun 30 August 13, 2026 4:41 PM - SEC Filing Form 8-K Edesa Biotech, Inc. For: Aug 13 August 13, 2026 4:20 PM - SEC Filing Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results August 13, 2026 4:15 PM - Globe NewsWire Form 4 Edesa Biotech, Inc. For: Aug 03 Filed by: Nijhawan Pardeep August 4, 2026 5:02 PM - SEC Filing Full Article List